Rekombinanter HLA-DRA Antikörper
-
- Target Alle HLA-DRA Antikörper anzeigen
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DRA Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Klon
- MSVA-470R
- Isotyp
- IgG
- Top Product
- Discover our top product HLA-DRA Primärantikörper
-
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-254) antibody
HLA-DRA Reaktivität: Human WB, IHC, FACS, ELISA, ICC Wirt: Maus Monoclonal 1C11A5 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-216) antibodyHLA-DRA Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 27-216) antibodyHLA-DRA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 48-75), (N-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19526 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 1-254) antibodyHLA-DRA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC, FACS, IF, StM Wirt: Maus Monoclonal 19-26-1-same as MB-26-1 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human, Maus, Ratte WB, IHC, IF, ELISA, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-221) antibodyHLA-DRA Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 149-177), (C-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB19527 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:100-1:200
- Kommentare
-
Positive Control: Liver: An at least moderate staining should be seen of sinusoids and Kupffer cells. Kidney: An at least moderate staining should be seen in small capillaries of glomeruli.
Negative Control: Absence of HLA-DRa staining is expected in hepatocytes of a completely normal liver and in tubuli of completely normal kidney.
- Protokoll
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Andere Bezeichnung
- HLA-DRa (HLA-DRA Produkte)
- Synonyme
- HLA-DRA1 antikoerper, MLRW antikoerper, DR-alpha antikoerper, HLA-DRA antikoerper, Mamu-DRA1 antikoerper, major histocompatibility complex, class II, DR alpha L homeolog antikoerper, major histocompatibility complex, class II, DR alpha antikoerper, hla-dra.L antikoerper, HLA-DRA antikoerper, MAMU-DRA antikoerper, BOLA-DRA antikoerper
- Hintergrund
- DR alpha chain, DRB1, DRB4, HLA class II histocompatibility antigen DR alpha chain, HLA DR1B, HLA DR3B, HLA DRA, HLA-DRA, HLADR4B, HLADRA1, HLADRB, Major histocompatibility complex class II DR alpha, Major histocompatibility complex class II DR beta 1/3/4/5,HLA-DRa antibody validated for immunohistochemistry on 76 different Normal Tissues
- UniProt
- P01903
- Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events
-
